Find the right doctor.Get information about our new institute structure.my health. MyChart.Find the right doctor.

Mikkael Sekeres, M.D., M.S.

Print this Content
Email this Content
Appointed: 2002
Gender: Male
Languages: English
Hematologic Oncology and Blood Disorders
Phone:(216) 445-9353
Location:Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
Translational Hematology and Oncology Research
Phone:(216) 445-9353
Location:Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
 
 
Professional Highlights
  • Co-Chair, Medical Advisory Board, Aplastic Anemia and Myelodysplastic Syndromes International Foundation
  • Member, National Cancer Institute PDQ Adult Treatment Editorial Board
  • Reviewer, Blood, Cancer, Lancet, Clinical Cancer Research, Oncology, Leukemia Research, British Journal of Haematology, Cancer Investigation
  • Member, Oncologic Drugs Advisory Committee, F.D.A.
  • Director, Myelodysplastic Syndromes Program Reviewer, Journal of Clinical Oncology
Back to Top
Education & Fellowships
Medical School:University of Pennsylvania School of Medicine, Philadelphia, PA
 
Residency:Massachusetts General Hospital, Internal Medicine, Boston, MA
Fellowship:Dana-Farber Cancer Institute, Hematology/Oncology, Boston, MA
Other Education:(Graduate) University of Pennsylvania, Philadelphia, PA
Other Education:(Undergraduate) University of Pennsylvania, Philadelphia, PA
Back to Top
Additional Training
  • Coursework, Harvard School of Public Health, 2000
  •  Leading in Healthcare course, Cleveland Clinic, 2008
Back to Top
Certifications

Medical Oncology

Internal Medicine

Back to Top
Specialty Interests
Acute Myeloid Leukemia, bone marrow failure syndromes/disorders, chronic myelogenous leukemia, Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Hairy Cell Leukemia, Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL).
Back to Top
Awards & Honors
  • Phi Beta Kappa, University of Pennsylvania, 1991
  • Magna cum Laude, University of Pennsylvania, 1991
  • “Bridging the Gaps” Community Service Achievement Award, University of Pennsylvania School of Medicine, 1995
  • Alpha Omega Alpha, University of Pennsylvania School of Medicine, 1995
  • American Federation for Clinical Research Award, University of Pennsylvania School of Medicine, 1996
  • Study Sections, RFA-HL-04-033 (Myelodysplastic Syndromes) and RFA-HL-04-034 (Myeloproliferative Disorders), National Heart, Lung and Blood Institute, 2005
  • Moderator, American Society of Hematology Annual Meeting, Myelodysplastic Syndromes: Clinical Studies session, 2005, 2007
  • Moderator, American Society of Hematology Annual Meeting, Acute Myeloid Leukemia: Therapies Excluding Transplant, 2008
  • Scientific Discussant, American Society of Clinical Oncology Annual Meeting: Leukemia, Myelodysplasia, and Transplantation Session, 2008
  • Education Session chair, American Association of Blood Bankers Annual Meeting: Myelodysplastic Syndromes, 2009
  • Education Session chair, American Society of Hematology Annual Meeting: Myelodysplastic Syndromes, 2009
  • Best Doctors, Cleveland Magazine, 2008, 2009
Back to Top
Professional Memberships
  • American Society of Hematology
  • Southwest Oncology Group, Leukemia Committee
  • American Society of Clinical Oncology
Back to Top
Specializes in Diseases and Conditions
Back to Top
Specializes in Services
Back to Top
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Sekeres has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting.  Dr. Sekeres receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
  • Celgen Corporation
  • Network for Medical Communications and Research
  • Oncology Associates, LLC
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)